In today’s briefing:
- NIO (9866 HK) Secondary Listing: HSTECH Inclusion in June Likely
- HSCEI Index Rebalance Preview (June): Great Wall Motor (2333) Should Replace Hansoh Pharma (3692)
- Arrail Group (瑞尔集团) IPO: Downsized Deal Mostly Taken by Cornerstones
- Chinese Metal Giant Faces Heavy Losses on Wild Nickel Ride
- Jinmao Property Services IPO Trading – Expect a Modest Debut with Low Liquidity
- Arrail IPO: Strong Growth Prospects with Further Upside to Margins
- Bilibili: All Things Point to Slowdown in Earnings Growth
- Pre IPO Ascent ENT Group Holdings – Conservative About the Outlook
- Morning Views Asia: China SCE, KWG Living Group
NIO (9866 HK) Secondary Listing: HSTECH Inclusion in June Likely
- NIO Inc (9866 HK) is expected to list on the HKEX (388 HK) tomorrow. Nearly 820m Class A shares are now held on the Hong Kong Share Register.
- We do not expect NIO Inc (9866 HK) to get Fast Entry to the HSCEI INDEX and HSTECH INDEX, though inclusion in the HSTECH could take place in June.
- NIO Inc (9866 HK) is not likely to get Fast Entry to the HSCI. The stock is not eligible for Southbound Stock Connect as a Secondary Listing.
HSCEI Index Rebalance Preview (June): Great Wall Motor (2333) Should Replace Hansoh Pharma (3692)
- Great Wall Motor (2333 HK) could replace Hansoh Pharmaceutical (3692 HK) in the Hang Seng China Enterprises Index (HSCEI INDEX) at the June rebalance. The review period ends 31 March.
- Bilibili (9626 HK) is a close add while Sunac China Holdings (1918 HK) is a close delete. Stock prices moves over the next 3 weeks will decide on the changes.
- Passive HSCEI Index trackers will need to buy 1.74 days of ADV on Great Wall Motor (2333 HK) and sell over 3 days of ADV on Hansoh Pharmaceutical (3692 HK).
Arrail Group (瑞尔集团) IPO: Downsized Deal Mostly Taken by Cornerstones
- Arrail is a leading premium dental service provider in China. The company launched book building to raise up to USD 87m via a Hong Kong listing.
- In our previous notes, we looked at the company’s background, its operation, its financials, and its expansion plan, and compared its key metrics with peers and provide thoughts on valuation.
- In this note, we provide a quick update for the book building.
Chinese Metal Giant Faces Heavy Losses on Wild Nickel Ride
- A Chinese metal giant is scrambling to manage massive losses from shorting nickel futures after the metal went on an unprecedented rally.
- Tsingshan Holding Group Ltd., one of the world’s biggest nickel and stainless steel producers, came under mounting pressure to meet margin calls for its short position
- The price of the metal, used in stainless steel and electric-vehicle batteries, surged as much as 250% in two days
Jinmao Property Services IPO Trading – Expect a Modest Debut with Low Liquidity
- Jinmao Property Services (816 HK) raised around US$105m in its Hong Kong IPO.
- In our view, the firm doesn’t deserve to trade at a premium to peers given its weaker margins and slower growth in FY20.
- In this note, we will look at the trading dynamics and current valuation.
Arrail IPO: Strong Growth Prospects with Further Upside to Margins
- Arrail is the largest dental services provider in China’s premium private dental service market and the third in the overall market in terms of total revenues in 2020.
- The company has filed for an IPO to list on the Hong Kong Stock Exchange and plans to raise about US$86m.
- The group has experienced strong growth despite the impact of COVID-19 and China’s growing private dental market offers large potential for the company to grow.
Bilibili: All Things Point to Slowdown in Earnings Growth
- Bilibili Inc (BILI US) reported 4Q2021 results last week where revenues increased 50.6% YoY to RMB 5.8bn while operating losses increased to RMB 2bn compared to RMB 903m in 4Q2020.
- This marks the lowest YoY growth in top line since 2Q2019. Though all segments experienced YoY growth in revenue, we have observed that the growth is slowing down.
- The company also has announced a share buyback of up to US$500m of its ADS over the next 24 months
Pre IPO Ascent ENT Group Holdings – Conservative About the Outlook
- For ENT services, the number of patients and scale of ENT field are relatively stable, with growth ceiling.
- Due to the limited doctor resources in Singapore and the intensified multi-party competition faced by Ascent, there may not be exciting future growth potential.
- So, we are conservative about the Company’s outlook if it just operates the business within Singapore or without diversifying its business effectively.
Morning Views Asia: China SCE, KWG Living Group
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
Before it’s here, it’s on Smartkarma